<DOC>
	<DOCNO>NCT00373776</DOCNO>
	<brief_summary>This trial study miltefosine treatment mucosal leishmaniasis .</brief_summary>
	<brief_title>Miltefosine Mucosal Leishmaniasis</brief_title>
	<detailed_description>Treat bolivian mucosal leishmaniasis miltefosine .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Miltefosine</mesh_term>
	<criteria>Mucosal leishmaniasis Abnormal liver function test ( LFT ) Abnormal kidney function test Concomitant disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>mucosal</keyword>
	<keyword>leishmaniasis</keyword>
	<keyword>miltefosine</keyword>
</DOC>